triiodothyronine has been researched along with cimetidine in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (42.86) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 7 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hori, S; Kikkawa, T; Mori, S; Ohtsuki, S; Otagiri, M; Takanaga, H; Terasaki, T | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Hayashi, S; Kato, A; Mizuno, K; Morita, A; Nakata, E; Ohashi, K; Yamamura, K | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bertaccini, G; Ceda, GP; Scarpignato, C; Valenti, G | 1 |
| Hugues, JN; Louchahi, M; Modigliani, E; Perret, G; Varoquaux, O | 1 |
| Itoh, S; Matsuo, S; Nakajima, M; Yamaba, Y | 1 |
| Carlson, HE; Chang, RJ | 1 |
| Bianco, AC; Douglas, CR; Douglas, RA; Martins, O; Nunes, MT; Pereira, RC; Roesner, I | 1 |
| Kamijo, K; Kato, T; Kawasaki, K; Saito, A; Suzuki, M; Wada, T; Yabana, T; Yachi, A | 1 |
1 review(s) available for triiodothyronine and cimetidine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for triiodothyronine and cimetidine
| Article | Year |
|---|---|
Effect of a short-term oral administration of cimetidine and ranitidine on the basal and thyrotropin-releasing hormone-stimulated serum concentrations of prolactin, thyrotropin and thyroid hormones in healthy volunteers. A double-blind cross-over study.
Topics: Adult; Cimetidine; Double-Blind Method; Humans; Male; Prolactin; Random Allocation; Ranitidine; Thyroid Hormones; Thyrotropin; Thyrotropin-Releasing Hormone; Triiodothyronine | 1986 |
12 other study(ies) available for triiodothyronine and cimetidine
| Article | Year |
|---|---|
Mouse reduced in osteosclerosis transporter functions as an organic anion transporter 3 and is localized at abluminal membrane of blood-brain barrier.
Topics: Animals; Biological Transport; Blood-Brain Barrier; Capillaries; Disease Models, Animal; Estrone; Male; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Osteosclerosis; Penicillin G; RNA, Messenger | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Discovery of {1-[4-(2-{hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl}-1H-benzimidazol-1-yl)piperidin-1-yl]cyclooctyl}methanol, systemically potent novel non-peptide agonist of nociceptin/orphanin FQ receptor as analgesic for the treatment of neuropathic pain: de
Topics: Analgesics; Animals; Benzimidazoles; Drug Design; Drug Evaluation, Preclinical; Humans; Microsomes, Liver; Neuralgia; Nociceptin Receptor; Pyrroles; Rats; Receptors, Opioid; Structure-Activity Relationship | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Effects of cimetidine on the secretion of some pituitary hormones.
Topics: Adult; Cimetidine; Follicle Stimulating Hormone; Growth Hormone; Guanidines; Humans; Injections, Intravenous; Luteinizing Hormone; Male; Pituitary Hormone-Releasing Hormones; Pituitary Hormones, Anterior; Prolactin; Secretory Rate; Thyrotropin; Thyrotropin-Releasing Hormone; Triiodothyronine | 1979 |
T3/T4 ratio in cimetidine treatment.
Topics: Cimetidine; Humans; Thyroxine; Triiodothyronine | 1986 |
Studies on the role of histamine in human pituitary function.
Topics: Adult; Betazole; Cimetidine; Diphenhydramine; Female; Growth Hormone; Histamine; Humans; Levodopa; Male; Middle Aged; Pituitary Function Tests; Pituitary Gland; Prolactin; Thyrotropin; Thyrotropin-Releasing Hormone; Triiodothyronine | 1980 |
Possible mechanism of action of cholesterol enriched diet on the thyroid.
Topics: Animals; Cholesterol, Dietary; Cimetidine; Hypothalamo-Hypophyseal System; Iodine; Male; Rats; Rats, Inbred Strains; Thyroid Gland; Thyroidectomy; Thyrotropin; Thyroxine; Triiodothyronine | 1981 |
Effect of cimetidine on prolactin secretion in normal controls and hyperthyroid patients.
Topics: Adult; Cimetidine; Female; Guanidines; Humans; Hyperthyroidism; Kinetics; Methimazole; Prolactin; Propylthiouracil; Thyroxine; Triiodothyronine | 1982 |